Change is hard in healthcare. But does that mean we should not try?
Of course not.
@prophetstrategy compiled a playbook on how to innovate in the face of risk aversion and regulations.
I contributed thoughts on health equity and personalization.
Read: https://t.co/HmhUfIxxji?
In this episode if Microdosing from #ASCO22, Natalie Sacarakis of IQVIA talks about how they address the unique logistics management and clinical operations challenges around one's cell and gene therapy asset and pipeline.
Spotify:…https://t.co/aHKCIqViUd
I had a chance to catch-up with Chelsea Saurer and Kesem - one of my all-time favorite non-profits - at #ASCO22 today. She shares more in the latest episode of Microdosing.
Spotify: https://t.co/SKcghCSAm1
Other platforms: https://t.co/AMpbQhf00d
Tha…https://t.co/ExopNxPu76
In the latest Microdosing episode here from #asco22, Jen-Tang Lu, PhD of Vysioneer talks about how they are using AI to unlock real-world guideline-based tumor response assessments, and improve clinical trials in that space.
We are sharing more stories…https://t.co/iFlc6Cuc4D
As Danny and I continue to promote #happyfriday as a way to share more moments of workplace joy, I wanted to give a quick shoutout to @tracyatriordan and @scottdavisshift for spearheading Prophet Chicago's night out at the Cubs game this week. Complete…https://t.co/SdU1IOZFO4
The Water Trust prides itself on bringing an innovative, scientific, and data approach to everything we do. It was great to collaborate with The World Bank on our latest analysis.
#wash#innovation#sustainability Prophet Jill Steele https://t.co/bfFSqzhvZd
The two big EMR players Epic and Cerner Corporation are fun to watch right now. The EMR market is largely matured and saturated, and that "customer base" is comprised of health systems that operate on very low margin. This latest…https://t.co/7eUJ9N8Wsc https://t.co/gsTyk8FfZi